United States - English - NLM (National Library of Medicine)

cantrell drug company - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz), bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) -

United States - English - NLM (National Library of Medicine)

prostrakan, inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 100 ug - abstral (fentanyl) sublingual tablets are indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine daily, or at least 25 mcg of transdermal fentanyl/hour, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or at least 25 mg oral oxymorphone daily, or an equianalgesic dose of another opioid medication daily for a week or longer. patients must remain on around-the-clock opioids when taking abstral. abstral is contraindicated for patients who are not already tolerant to opioids because life-threatening respiratory depression and death could result at any dose in patients not on a chronic regimen of opioids. for this reason, abstral is contraindicated in the management of acute or postoperative pain,

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

kalceks jsc - fentanyl (fentanyl citrate) - solution for injection - 0,05mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

kalceks jsc - fentanyl (fentanyl citrate) - solution for injection - 0,05mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 785 microgram (equivalent: fentanyl, qty 500 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - short duration analgesia during premedication, induction and maintenance of anaesthesia, and in the immediate postoperative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic premedication for the induction of anaesthesia, and as an adjunct in the maintanance of general and regional anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 157 microgram (equivalent: fentanyl, qty 100 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - short duration analgesia during premedication, induction and maintenance of anaesthesia, and in the immediate postoperative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic premedication for the induction of anaesthesia, and as an adjunct in the maintanance of general and regional anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 2513.6 microgram (equivalent: fentanyl, qty 1600 microgram) - lozenge with integral application - excipient ingredients: citric acid; starch sodium octenyl succinate; dextrates; dibasic sodium phosphate; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 1885.2 microgram (equivalent: fentanyl, qty 1200 microgram) - lozenge with integral application - excipient ingredients: starch sodium octenyl succinate; dibasic sodium phosphate; dextrates; citric acid; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 1256.8 microgram (equivalent: fentanyl, qty 800 microgram) - lozenge with integral application - excipient ingredients: citric acid; dibasic sodium phosphate; starch sodium octenyl succinate; dextrates; magnesium stearate; shellac; brilliant blue fcf; flavour; maize starch; sucrose - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 942.6 microgram (equivalent: fentanyl, qty 600 microgram) - lozenge with integral application - excipient ingredients: starch sodium octenyl succinate; dextrates; magnesium stearate; dibasic sodium phosphate; citric acid; shellac; brilliant blue fcf; maize starch; sucrose; flavour - actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.